Placebo News and Research

RSS

Researchers reveal how to effectively achieve and maintain a healthy weight loss

Almost one in five Danes live with obesity, which may have serious health consequences. In the world's most recognized medical journal, Danish researchers now document how to effectively achieve and maintain a healthy weight loss.

6 May 2021

Study: Novavax Covid-19 vaccine is efficacious against the B.1.351 South African variant

The published data provide additional detail of an initial analysis conducted in January, while more robust data from a complete analysis of the study was subsequently shared in March 2021.

6 May 2021

Low doses of ionizing radiation may be a promising therapy for people with Alzheimer’s disease

Individuals living with severe Alzheimer's disease showed remarkable improvements in behavior and cognition within days of receiving an innovative new treatment that delivered low doses of radiation, a recent Baycrest-Sunnybrook pilot study found.

3 May 2021

FDA approves new drug for treatment of adults with chronic kidney disease

Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.

30 Apr 2021

Daily prebiotic intake can reduce anxiety levels and improve wellbeing

A new study from the University of Surrey has found that 4-weeks of daily galacto-oligosaccharides (GOS) prebiotic intake can reduce anxiety levels and result in an overall improvement in wellbeing in young women.

27 Apr 2021

New treatment approach could be life-changing for many stroke patients

Every year, more than 795,000 people in the United States have a stroke. Of these, approximately 80% lose arm function and as many as 50-60% of this population still experience problems six months later.

26 Apr 2021

Single dose of J&J's Ad26.COV2.S vaccine effective against SARS-CoV-2 including in South Africa variant

One of these vaccines, the Ad26.COV2.S vaccine by Johnson & Johnson and Janssen, is a recombinant, replication-incompetent human adenovirus type 26 vector that encodes full-length SARS-CoV-2 spike protein in a prefusion-stabilized conformation.

26 Apr 2021

Recombinant protein vaccine fails expectations for SARS-CoV-2 neutralization

New interim results of a phase 1-2 clinical trial published in The Lancet Infectious Diseases tested the safety and effectiveness of an adjuvanted recombinant protein vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) called CoV2 preS dTM.

26 Apr 2021

Potential new COVID vaccine from Australia

Phase 1 trial results published in The Lancet Infectious Diseases found a new subunit vaccine —an MF59-adjuvanted subunit vaccine using recombinant spike glycoprotein stabilized in a prefusion conformation by a novel molecular clamp — targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was safe and effective in producing an antigen-specific response in healthy adults.

26 Apr 2021

High dose of vitamin D does not have a beneficial effect on moderate or severe COVID-19 patients

Can a high dose of vitamin D administered on admission to hospital improve the condition of patients with moderate or severe COVID-19? The answer is no, according to a Brazilian study published in the Journal of the American Medical Association.

23 Apr 2021

Study sheds light on the ability of CBD to reduce pain

It's been hailed as a wonder drug and it's certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could be worth $20 billion dollars by 2024.

23 Apr 2021

Ankle exoskeleton system increases self-selected walking speed

Being unable to walk quickly can be frustrating and problematic, but it is a common issue, especially as people age.

23 Apr 2021

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).

23 Apr 2021

Placebo News and Research

Researchers reveal how to effectively achieve and maintain a healthy weight loss

Study: Novavax Covid-19 vaccine is efficacious against the B.1.351 South African variant

Low doses of ionizing radiation may be a promising therapy for people with Alzheimer’s disease

FDA approves new drug for treatment of adults with chronic kidney disease

Daily prebiotic intake can reduce anxiety levels and improve wellbeing

New treatment approach could be life-changing for many stroke patients

Single dose of J&J's Ad26.COV2.S vaccine effective against SARS-CoV-2 including in South Africa variant

Recombinant protein vaccine fails expectations for SARS-CoV-2 neutralization

Potential new COVID vaccine from Australia

High dose of vitamin D does not have a beneficial effect on moderate or severe COVID-19 patients

Study sheds light on the ability of CBD to reduce pain

Ankle exoskeleton system increases self-selected walking speed

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

Clinical trial examines metabolic effects of natural compound NMN in people

New Phase 3 trial of therapeutics begins enrolling severely ill hospitalized COVID-19 patients

NCCS starts clinical trial to examine the use of TCM in countering cancer-related symptoms

Argonne's Advanced Photon Source guided the development of new COVID-19 vaccine now in trials

Probiotic strain improves iron levels in healthy pregnant women

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

Genethon announces dosing of first patient at pediatric clinical trial platform for neuromuscular diseases

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News